Athletes can feel the relief a substance gives them long before they can see what it costs. A composite case of cannabis use in a track athlete shows how to assess both.
|Videos|May 1, 2020
Special Issues for Patients With Bipolar Disorder Coping With COVID-19
Author(s)Melvin G. Mcinnis, MD, FRCPsych
Patients with bipolar disorder often find it difficult to maintain schedules and routines, all the more challenging with the COVID-19 pandemic. More in this video.
Advertisement
Patients with
Advertisement
Related to this article
Andrew A. Nierenberg, MD, explains how a learning health network helps clinicians measure outcomes and redesign bipolar disorder care together with patients.
Seaport begins phase 2a trial of GlyphAgo for generalized anxiety disorder with sleep disturbance, testing liver-sparing agomelatine dosing and tracking sleep, anxiety outcomes.
Advertisement
Advertisement
Trending on Psychiatric Times
1
Antipsychotic Plasma Levels in Schizophrenia: Detecting Nonadherence and Guiding Dose Decisions
2
Choosing an Antidepressant: Art, Science, and Knowing Your Patient
3
Relief Is Not Free: A Case Study of Athlete Cannabis Use
4
Responding to Intimate Partner Violence Disclosures in Psychiatry
5